Cargando…

Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study

INTRODUCTION: The aim of our study was to investigate the association between arthritic disease activity and antibodies to mutated citrullinated vimentin (anti-MCV), because such a relation has been suggested. METHODS: Anti-MCV levels were measured in 162 patients with early arthritis (123 with rheu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ursum, Jennie, Nielen, Markus MJ, van Schaardenburg, Dirkjan, van der Horst, Ann R, van de Stadt, Rob J, Dijkmans, Ben AC, Hamann, Dörte
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374444/ https://www.ncbi.nlm.nih.gov/pubmed/18226202 http://dx.doi.org/10.1186/ar2362

Ejemplares similares

Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study
por: Ursum, Jennie, et al.
Publicado: (2010)

Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems
por: Ursum, Jennie, et al.
Publicado: (2009)

Development of anti-citrullinated protein antibody and rheumatoid factor isotypes prior to the onset of rheumatoid arthritis
por: Bos, Wouter H, et al.
Publicado: (2014)

Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial
por: van Eijk, Izhar C., et al.
Publicado: (2012)

The rheumatoid arthritis specific Sa antigen is citrullinated vimentin
por: Vossenaar, ER, et al.
Publicado: (2004)

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis
por: Van Steendam, Katleen, et al.
Publicado: (2011)

The validity of the diagnosis of inflammatory arthritis in a large population-based primary care database
por: Nielen, Markus MJ, et al.
Publicado: (2013)

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
por: Vossenaar, Erik R, et al.
Publicado: (2004)

Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
por: Van Steendam, Katleen, et al.
Publicado: (2010)

Cardiovascular risk in persons at risk of developing rheumatoid arthritis
por: van Boheemen, Laurette, et al.
Publicado: (2020)

The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
por: Guseinova, D, et al.
Publicado: (2008)

Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis
por: Gilliam, Brooke E, et al.
Publicado: (2013)

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
por: Dejaco, Christian, et al.
Publicado: (2006)

Increased primary care use for musculoskeletal symptoms, infections and comorbidities in the years before the diagnosis of inflammatory arthritis
por: van Beers-Tas, Marian, et al.
Publicado: (2020)

Increased risk for chronic comorbid disorders in patients with inflammatory arthritis: a population based study
por: Ursum, Jennie, et al.
Publicado: (2013)

Pattern of drugs use and association with anti-mutated citrullinated vimentin antibody in rheumatoid arthritis
por: Safi, Mohammad-Ayman A., et al.
Publicado: (2015)

The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis
por: Avdeeva, A. S., et al.
Publicado: (2014)

The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study
por: van de Stadt, Lotte A, et al.
Publicado: (2010)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
por: Al-Shukaili, Ahmed, et al.
Publicado: (2012)

Depressive mood and low social support are not associated with arthritis development in patients with seropositive arthralgia, although they predict increased musculoskeletal symptoms
por: Holla, Jasmijn F M, et al.
Publicado: (2018)

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis
por: Gonzalez-Lopez, Laura, et al.
Publicado: (2014)

The value of joint ultrasonography in predicting arthritis in seropositive patients with arthralgia: a prospective cohort study
por: van Beers-Tas, Marian H., et al.
Publicado: (2018)

Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
por: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Publicado: (2011)

Forefoot disease activity in rheumatoid arthritis patients in remission: results of a cohort study
por: van der Leeden, Marike, et al.
Publicado: (2010)

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
por: Nicaise Roland, Pascale, et al.
Publicado: (2008)

Antibodies to Mutated Citrullinated Vimentin in Rheumatoid Arthritis: Diagnostic Value, Association with Radiological Damage and Axial Skeleton Affection
por: Mansour, Howaida E., et al.
Publicado: (2010)

Higher Levels of Autoantibodies Targeting Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis Than in Patients with Psoriasis Vulgaris
por: Dalmády, Szandra, et al.
Publicado: (2013)

How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators
por: van Boheemen, Laurette, et al.
Publicado: (2021)

Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis
por: Lindenberg, Luisa, et al.
Publicado: (2015)

Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
por: Norouzi, Somayye, et al.
Publicado: (2020)

Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
por: Salugina, SO, et al.
Publicado: (2008)

Citrullination of synovial proteins in murine models of rheumatoid arthritis
por: Vossenaar, E, et al.
Publicado: (2003)

How citrullination invaded rheumatoid arthritis research
por: van Venrooij, Walther J, et al.
Publicado: (2014)

A non-inferiority trial of an attenuated combination strategy (‘COBRA-light’) compared to the original COBRA strategy: clinical results after 26 weeks
por: den Uyl, Debby, et al.
Publicado: (2014)

Inhibiting citrullination in rheumatoid arthritis: taking fuel from the fire
por: Fisher, Benjamin AC, et al.
Publicado: (2012)

Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes
por: Frazzei, Giulia, et al.
Publicado: (2022)

Productivity at work and quality of life in patients with rheumatoid arthritis
por: van Vilsteren, Myrthe, et al.
Publicado: (2015)

IgG Anti–Citrullinated Protein Antibody Variable Domain Glycosylation Increases Before the Onset of Rheumatoid Arthritis and Stabilizes Thereafter: A Cross‐Sectional Study Encompassing ~1,500 Samples
por: Kissel, Theresa, et al.
Publicado: (2022)

Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing
por: Díaz-Toscano, Miriam Lizette, et al.
Publicado: (2014)

The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis
por: Pruijn, Ger JM, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1437rh69rc2n3f3j4f74o48jhu